Invited Speakers:
|
|
John Allocco, Merck & Co. Cenk Ayata, M.D., Harvard University Julia Billiard, Wyeth Robert Campbell, Ph.D., Senior Research Advisor, Eli Lilly & Company Jagabandhu Das, Bristol Myers Squibb Erin DiMauro, Amgen, Inc. Jessie English, Ph.D. (Keynote Speaker), Director, Kinase Center of Emphasis, Pfizer, Inc. Frank Gillardon, CNS Research, Boehringer Ingelheim Pharmaceuticals, Inc. Brian Hare, Investigator, Modeling and Informatics, Vertex Pharmaceuticals, Inc. Yansnori Hayashi, M.D., Ph.D., Assistant Professor of Neurobiology, MIT Carsten Hopf, Ph.D.,Group Leader Target Discovery, Cellzome AG Paul Jackson, Ph.D. (Conference Chair), Team Leader, CNS Research, Johnson & Johnson PRD Sanjay Khandekar, Gene Expression and Protein Biochemistry, GlaxoSmithKline Bert Klebl, Ph.D., Senior Director, Discovery Biology, GPCbiotech Gabriel Mbalaviele, Department of Inflammation, Pfizer, Inc. Mark McCoy, Schering-Plough Research Institute Mark Merchant, Ph.D., Scientist, Department of Translational Oncology, Genentech, Inc. Ravi Natarajan, Research Fellow, Merck & Co. Sridhar Rabindran, Ph.D., Associate Director, Oncology Research, Wyeth Research Jamal Saeh, Ph.D., Computational Chemist, Cancer Chemistry Department, AstraZeneca Maria L. Webb, Ph.D., VP, Preclinical Research, Biological and Pharmacological Sciences, Pharmacopeia Andrew West, Ph.D., Johns Hopkins University Hai-Ying Zhang, Ph.D., Department of Cancer Research, Abbott Laboratories Sean G. Buchanan, Ph.D., Senior Director, Discovery Biology, SGX Pharmaceuticals Elena Izmailova, Ph.D. , Senior Scientist, Millennium Pharmaceuticals, Inc.
|
|